Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer: Protracted Selloff Makes This Best Time To Buy For A Decade
07:44am, Monday, 25'th Sep 2023
Pfizer's revenues were declining prior to the pandemic, but the success of its COVID vaccine and antiviral brought in unexpected additional revenues of >$55bn over 2 years. The company has been on a m
Three-Stock Lunch: Pfizer, Alibaba, and eBay
03:54pm, Friday, 22'nd Sep 2023
Malcolm Ethridge, executive vice president at CIC Wealth Management, joins 'Power Lunch' to discuss his investing take on three stocks: Pfizer, Alibaba, and eBay.
Pfizer maternal RSV vaccine recommended by CDC advisors
02:58pm, Friday, 22'nd Sep 2023
A Centers for Disease Control and Prevention advisory committee on Friday recommended pregnant people get Pfizer Inc.'s PFE, -0.56% maternal vaccine to protect babies from respiratory syncytial virus.
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
02:57pm, Friday, 22'nd Sep 2023
CDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer's shot to protect their infants from RSV.
Explainer: What you need to know about RSV and the new vaccines
12:29pm, Friday, 22'nd Sep 2023
Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Friday to discuss recommendations for use of the first vaccine for respiratory syncytial virus (RSV) approved for p
US CDC panel weighs use of Pfizer's maternal RSV vaccine to protect infants
11:39am, Friday, 22'nd Sep 2023
A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's respiratory syncytial virus (RSV) vaccine in pregnant women, likely paving t
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
01:54pm, Thursday, 21'st Sep 2023
AbbVie is entering a new era but is well prepared to return to its winning ways. Gilead Sciences offers investors steady and reliable performance and a great dividend.
2 Dividend Growth Stocks to Buy Right Now
09:37am, Thursday, 21'st Sep 2023
Amgen's prospects remain solid despite recent struggles. Pfizer is poised to show that it isn't just a pandemic stock.
Readers Post 32 August Dividend Buy Candidates
04:04pm, Wednesday, 20'th Sep 2023
Prior to August 31, 2023, my Readers mentioned 37 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, these are ReFa/Ro. Ten analyst-targ
Fall Covid shot rollout gets off to a bumpy start as some patients see insurance delays
10:56am, Wednesday, 20'th Sep 2023
The reports are fueling confusion among insured patients about whether they can still access Covid shots for free — just as cases tick up across the country.
ARS Pharma shares bomb on surprise FDA rebuff
08:42am, Wednesday, 20'th Sep 2023
Shares of ARS Pharmaceuticals Inc plummeted 51% in premarket trading after the US Food and Drug Administration (FDA) unexpectedly declined to approve its needle-free nasal spray, Neffy, designed for
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
07:45am, Wednesday, 20'th Sep 2023
Facing significant patent cliffs, Pfizer is putting faith in new launches. Moderna has nearly doubled its pipeline in three years.
Flee to Healthcare Stocks if Recession Rears its Head?
07:04am, Wednesday, 20'th Sep 2023
If you're looking for a sector that's on sale, look to healthcare. The Health Care Select Sector SPDR Fund NYSEARCA: XLV is down 2.50% in the past month, lagging the S&P 500.
AstraZeneca rises on completion of Pfizer gene therapy deal
04:31am, Wednesday, 20'th Sep 2023
AstraZeneca PLC (LSE:AZN) shares rose 2.4% to 10,868p after its Alexion rare disease unit sealed a deal to buy a portfolio of Pfizer's early-stage drugs to boost its footprint in the burgeoning fi
Most Ukrainian companies are fully operational after 18 months of war, Kyiv-based American Chamber of Commerce
11:51am, Tuesday, 19'th Sep 2023
A year and a half after Ukraine was invaded by Russia, 84% of the nation's companies are fully operational, according to a survey by the American Chamber of Commerce in Ukraine.
